Karuna Therapeutics Overview

Karuna Therapeutics Selling, General & Admin

Selling, General & Admin expenses for KRTX.

Quarterly SG&A Expenses

$47.39M

↑ 94.96% YoY

As of Dec 31, 2023

Annual SG&A Expenses (TTM)

$131.33M

↑ 72.65% YoY

Trailing 12 months ending Dec 31, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin